Chronic fatigue syndrome: a biological approach.

Introduction Interferon and the 2-5A/Pathway, L. Bastide, E. Demettre, C. Martinand-Mari, and B. Lebleu Ribonuclease L: Overview of a Multifaceted Protein, P. Englebienne, C.V. Herst, S. Roelens, A. D'Haese, K. El Bakkouri, K. De Smet, M. Fremont, L. Bastide, E. Demettre, and B. Lebleu A 37-kDa RNase L: A Novel Form of RNase L Associated with Chronic Fatigue Syndrome, R.J. Suhadolnik, S.E. Shetzline, C. Martinand-Mari, and N.L. Reichenbach Ribonuclease L Inhibitor: A Member of the ATP-Binding Cassette Superfamily, P. Englebienne, C.V. Herst, A. D'Haese, K, De Meirleir, L, Bastide, E, Demettre, and B, Lebleu The 2-5A Pathway and Signal Transduction: A Possible Link to Immune Dysregulation and Fatigue, P. Englebienne, C.V. Herst, M. Fremont, T. Verbinnen, M. Verhas, and K. De Meirleir Immune Cell Apoptosis and Chronic Fatigue Syndrome, M. Fremont, A. D'Haese, S. Roelens, K. De Smet, C.V. Herst, and P. Englebienne RNase L, Symptoms, Biochemistry of Fatigue and Pain, and Co-Morbid Disease, N.R. McGregor, P. De Becker, and K. De Meirleir CFS Etiology, the Immune System, and Infection, K. De Meirleir, P. De Becker, J. Nijs, D.L. Peterson, G. Nicolson, R. Patarca-Montero, and P. Englebienne Current Advances in CFS Therapy, P. De Becker, N.R. McGregor, K. De Smet, and K. De Meirleir From Laboratory to Patient Care, K. De Meirleir, D.L. Peterson, P. De Becker, and P. Englebienne Index